Yang Zhao

Yang Zhao has worked as a Senior Principal Scientist at Boehringer Ingelheim since July 2023. Prior to that, they were a Principal Scientist at The Janssen Pharmaceutical Companies of Johnson & Johnson from June 2020 to June 2023. Yang also has extensive experience at Eli Lilly and Company, where they held roles as a Senior Scientist and Scientific Team Leader of Immunology and Immuno-Oncology programs from October 2015 to May 2020. Additionally, they worked as a Research Scientist and as a Postdoctoral Research Fellow at the same company from October 2009 to September 2015 and from August 2007 to September 2009, respectively.

Yang Zhao received a Ph.D. in Cell Biology from the University of Michigan, where they studied from 2001 to 2007.